Article Text

Download PDFPDF

CASE REPORT
Utility of autonomic testing for the efficient diagnosis and effective pharmacological management of neurogenic orthostatic hypotension
  1. Sami bin Alam,
  2. Waiel Almardini and
  3. Amer Suleman
  1. The Heartbeat Clinic, McKinney, Texas, USA
  1. Correspondence to Dr Sami bin Alam, sba0801{at}gmail.com

Abstract

A 62-year-old man presented with a 2-year history of syncope, collapse and fluctuating blood pressure (BP). His medications included midodrine (10 mg, three times per day) and fludrocortisone (0.1 mg, two times per day), but neither treatment afforded symptomatic relief. Autonomic testing was performed. Head-up tilt table testing revealed a supine BP of 112/68 mm Hg (heart rate, 74 beats per minute (bpm)) after 6 min, which dropped to 76/60 mm Hg (83 bpm) within 2 min of 80° head-up tilt. Findings from a heart rate with deep breathing test and a Valsalva test were consistent with autonomic dysfunction. The patient was diagnosed with neurogenic orthostatic hypotension and treated with droxidopa (100 mg, two times per day; titrated to 100 mg, one time per day). After initiating treatment with droxidopa, the patient no longer reported losing consciousness on standing and experienced improvement in activities of daily living. These improvements were maintained through 1 year of follow-up.

  • clinical diagnostic tests
  • cardiovascular system
  • neurology (drugs and medicines)
  • medical management
  • clinical neurophysiology

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SBA, WA and AS contributed to the acquisition, analysis and interpretation of data; participated in drafting the manuscript; critically revised the manuscript for intellectual content and approved the final version of the manuscript for publication. All authors agree to be accountable for the article and to ensure that all questions regarding the accuracy or integrity of the article are investigated and resolved.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests SBA received support from Lundbeck for travel and registration fees. WA has nothing to disclose. AS has received honoraria for serving on advisory boards for Lundbeck.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.